Urano T - Search Results

1

Undesirable effects of citrus juice on the pharmacokinetics of drugs: focus on recent studies.

Saito M, Hirata-Koizumi M, Matsumoto M, Urano T, Hasegawa R. Saito M, et al. Among authors: urano t. Drug Saf. 2005;28(8):677-94. doi: 10.2165/00002018-200528080-00003. Drug Saf. 2005. PMID: 16048354 Review.

2

[Improvement of package insert CYP information for prescription drugs marketed in Japan].

Hirata-Koizumi M, Saito M, Urano T, Miyake S, Hasegawa R. Hirata-Koizumi M, et al. Among authors: urano t. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku. 2005;(123):12-8. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku. 2005. PMID: 16541745 Japanese.

3

A literature search on pharmacokinetic drug interactions of statins and analysis of how such interactions are reflected in package inserts in Japan.

Saito M, Hirata-Koizumi M, Urano T, Miyake S, Hasegawa R. Saito M, et al. Among authors: urano t. J Clin Pharm Ther. 2005 Feb;30(1):21-37. doi: 10.1111/j.1365-2710.2004.00605.x. J Clin Pharm Ther. 2005. PMID: 15659001

4

Points to consider on the non-clinical safety evaluation of anticancer drugs.

Nakae D, Onodera H, Fueki O, Urano T, Komiyama N, Sagami F, Kai S, Nishimura C, Inoue T. Nakae D, et al. Among authors: urano t. J Toxicol Sci. 2008 May;33(2):123-6. doi: 10.2131/jts.33.123. J Toxicol Sci. 2008. PMID: 18544904 Free article. Review.

5

Participation of elderly patients in registration trials for oncology drug applications in Japan.

Yonemori K, Hirakawa A, Komiyama N, Kouno T, Ando M, Fujiwara Y, Urano T, Akagawa H, Maruyama H, Toyoshima S. Yonemori K, et al. Among authors: urano t. Ann Oncol. 2010 Oct;21(10):2112-2118. doi: 10.1093/annonc/mdq070. Epub 2010 Mar 23. Ann Oncol. 2010. PMID: 20332138 Free article.

6

[Vaccinia immune globulin].

Takeuchi Y, Kimura M, Urano T, Nomura M, Nishimura C. Takeuchi Y, et al. Among authors: urano t. Kansenshogaku Zasshi. 1970 Jun;44(3):156-64. doi: 10.11150/kansenshogakuzasshi1970.44.156. Kansenshogaku Zasshi. 1970. PMID: 4195411 Japanese. No abstract available.

7

A magnetic anti-cancer compound for magnet-guided delivery and magnetic resonance imaging.

Eguchi H, Umemura M, Kurotani R, Fukumura H, Sato I, Kim JH, Hoshino Y, Lee J, Amemiya N, Sato M, Hirata K, Singh DJ, Masuda T, Yamamoto M, Urano T, Yoshida K, Tanigaki K, Yamamoto M, Sato M, Inoue S, Aoki I, Ishikawa Y. Eguchi H, et al. Among authors: urano t. Sci Rep. 2015 Mar 17;5:9194. doi: 10.1038/srep09194. Sci Rep. 2015. PMID: 25779357 Free PMC article.

8

Exploring Ethnic Differences in Toxicity in Early-Phase Clinical Trials for Oncology Drugs.

Ogura T, Morita S, Yonemori K, Nonaka T, Urano T. Ogura T, et al. Among authors: urano t. Ther Innov Regul Sci. 2014 Sep;48(5):644-650. doi: 10.1177/2168479014524582. Ther Innov Regul Sci. 2014. PMID: 30231453

9

[Consideration of clinical development for new anticancer drugs on Japan, proposal from approval reviewer].

Urano T. Urano T. Gan To Kagaku Ryoho. 2007 Feb;34(2):305-7. Gan To Kagaku Ryoho. 2007. PMID: 17301550 Japanese.

10

Serum anti-PT and anti-FHA antibody levels, and agglutinin titers after administration of acellular pertussis vaccines.

Kuno-Sakai H, Kimura M, Sato Y, Tsunoda A, Urano T, Isomura S, Kamiya H. Kuno-Sakai H, et al. Among authors: urano t. Acta Paediatr Jpn. 1989 Apr;31(2):120-6. doi: 10.1111/j.1442-200x.1989.tb01277.x. Acta Paediatr Jpn. 1989. PMID: 2516691

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

807 results

Search Page